Reduction in FeNO on anti-IL5 biologics is associated with clinical remission of severe asthma

被引:0
|
作者
Soendergaard, Marianne Baastrup [1 ]
Hansen, Susanne [1 ]
Haakansson, Kjell Erik Julius [2 ]
Von Bulow, Anna [1 ]
Bjerrum, Anne-Sofie [3 ]
Schmid, Johannes Martin [3 ]
Johnsen, Claus Rikard [4 ]
Hilberg, Ole [5 ]
Ulrik, Charlotte Suppli [2 ]
Porsbjerg, Celeste [1 ]
机构
[1] Bispebjerg Hosp, Resp Res Unit, Copenhagen, Denmark
[2] Hvidovre Univ Hosp, Dept Resp Med, Copenhagen, Denmark
[3] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark
[4] Gentofte Univ Hosp, Allergy Clin, Copenhagen, Denmark
[5] Sygehus Lillebaelt, Dept Resp Med, Vejle, Denmark
关键词
D O I
10.1183/13993003.congress-2024.PA5365
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
    Soendergaard, Marianne Baastrup
    Hansen, Susanne
    Hakansson, Kjell Erik Julius
    von Bulow, Anna
    Bjerrum, Anne-Sofie
    Schmid, Johannes Martin
    Johansson, Sofie Lock
    Rasmussen, Linda Makowska
    Johnsen, Claus Rikard
    Bertelsen, Barbara Bonnesen
    Krogh, Niels Steen
    Hilberg, Ole
    Ulrik, Charlotte Suppli
    Porsbjerg, Celeste
    ALLERGY, 2024,
  • [2] Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma
    Hekking, Pieter-Paul
    Zhang, Kayla
    Garrido, Carmen Paz Venegas
    Lopez-Rodriguez, Raquel
    Kjarsgaard, Melanie
    Mukherjee, Manali
    Nair, Parameswaran
    ALLERGY, 2024, 79 (08) : 2244 - 2247
  • [3] Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Nolasco, Santi
    Detoraki, Aikaterini
    Vatrella, Alessandro
    Calabrese, Cecilia
    Pelaia, Corrado
    Montagnolo, Francesca
    Scioscia, Giulia
    Valenti, Giuseppe
    D'Amato, Maria
    Caiaffa, Maria Filomena
    Triggiani, Massimo
    Scichilone, Nicola
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] CHANGE IN FENO AS A BIOMARKER OF RESPONSE TO ANTI-IL5/5R THERAPIES IN SEVERE ASTHMA
    Hearn, A. P.
    Kavanagh, J. E.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A80 - A80
  • [5] Arthritis, a new adverse effect of anti-IL5 biologics in severe asthma patients?
    Dupin, C.
    Morer, L.
    Phillips-Houlbracq, M.
    Deneuville, L.
    Lebrun, M.
    Tabeze, L.
    Juge, P.
    Taille, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Cetin, Gulden Pacaci
    Arslan, Bahar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1935 - 1936
  • [7] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [8] THE RELATIONSHIP BETWEEN FENO AND RESPONSE TO ANTI-IL5/5R BIOLOGIC THERAPIES IN SEVERE EOSINOPHILIC ASTHMA
    Hearn, A. P.
    Kavanagh, J.
    d'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A143 - A144
  • [9] Clinical Predictors of Treatment Failure to Anti-IL5 Therapy in Severe Eosinophilic Asthma
    Reihman, A. E.
    Liu, C.
    Cruse, M. H.
    Freid, L.
    Perez, N.
    Smith, V. L.
    Ferguson, L.
    Wechsler, M.
    Holguin, F.
    Manka, L.
    Sharma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] Change of Antibody Therapy in severe Eosinophilic Bronchial Asthma from Anti-IL5 to Anti-IL5 Receptor Antibodies
    Drick, N.
    Milger, K.
    Korn, S.
    Buhl, R.
    Schuhmann, M.
    Herth, F. J. F.
    Kendziora, B.
    Bergmann, K. C.
    Taube, C.
    Welte, T.
    Suhling, H.
    PNEUMOLOGIE, 2020, 74 : S9 - S10